Tesla Fades: Three Big Stories Are Moving the Stock Today and They're Pulling in Different Directions

Tesla shares slid ~3% to about $382 (down 15% YTD from $449.72) as three conflicting catalysts hit: a U.S. probe into Full Self-Driving covering ~3.2M vehicles (engineering analysis after nine crashes, one fatality) and Polymarket putting the chance of California robotaxis by June 30 at 13%. Bullish offset: launch of Terafab aiming to produce "hundreds of billions" of custom chips (CEO expects AI6 design by December; Samsung 2nm volume by late 2027), a long-horizon, capital-intensive bet. Stellantis access to Superchargers boosts incremental services revenue (Energy & Services was $3.37B in Q4 2025, +18% YoY) but erodes Tesla’s charging moat; prediction markets assign a 60.5% probability Q1 deliveries fall below 350,000, keeping near-term pressure on the stock.

Analysis

The immediate pressure on the equity is amplifying a multi-horizon disconnect: near-term headline and delivery volatility compresses sentiment while Tesla’s semiconductor and charging strategic moves change structural profit pools over years. If Tesla executes internal silicon at scale, it reallocates gross margin from foundries and fabless suppliers into Tesla’s FCF stream — but that transfer only manifests after multi-year capex, yield ramp and supply agreements, leaving a long period where the stock must trade on story rather than realized economics.

Sharing Superchargers accelerates monetization of existing physical assets at low incremental cost, converting a latent network asset into steady cash but simultaneously commoditizing a historic consumer differentiator. That erosion shifts where competition happens: customer acquisition economics move from charging exclusivity to software, warranty, and service economics; OEMs that plug into networks will see higher conversion rates while Tesla’s option value for premium pricing and resale may decline incrementally over several quarters.

Key catalysts separate by cadence: days-to-weeks for delivery prints and regulatory headlines that can reprice risk premia; 6–18 months for regulatory outcomes or pilot approvals that materially change robotaxi probability; 18–48 months for any internal fab to contribute meaningfully to margins. Investors should trade the jagged path — favor convex, time-focused instruments that hedge regulatory tail risk while keeping upside if Tesla’s multi-year silicon gamble or charging monetization surprises positively.

Key Decisions for Investors

• Buy TSLA 18-month LEAP call spread (long 18m call at ~150% of spot, short 18m call at ~200% of spot). Rationale: asymmetric exposure to multi-year semiconductor/robotaxi upside while capping premium outlay; risk = premium paid, reward = 2–4x if thesis reaccelerates over 12–36 months.
• Establish a 3–6 month protective collar on existing TSLA exposure: buy 3m 10–15% OTM puts and finance with selling 3m 10–20% OTM calls. Rationale: protects from regulatory headline or delivery misses in the near term while monetizing elevated IV; expect cost ~0–30% of underlying position depending on strikes.
• Pair trade: long STLA outright (or buy 9–12m call spread) and hedge by shorting TSLA equity (or buying TSLA 3–6m put spread). Rationale: capture incremental Supercharger cashflow and improved OEM EV conversion vs. downside concentrated in Tesla from regulatory and execution risk; target asymmetric payoff with 12m time horizon and 15–25% expected relative outperformance.
• Long semiconductor capital-equipment exposure (ASML, LRCX, AMAT) 6–24 months via outright long or call spreads. Rationale: Tesla’s fab ambition increases bidding for tooling/capex and supports multiple-cycle demand; tail risk is project delay, so size position for 20–40% downside buffer and 2–3x upside if capex commitments accelerate.